Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications. - Wikidata - wikimedia - TriplyDB

Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

http://www.wikidata.org/entity/Q37792817

about

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.Meta-analysis of best corrected visual acuity after treatment for myopic choroidal neovascularisation.Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.Angiopoietin-like Protein 2 Is a Multistep Regulator of Inflammatory Neovascularization in a Murine Model of Age-related Macular Degeneration.Myeloid-Specific Blockade of Notch Signaling Attenuates Choroidal Neovascularization through Compromised Macrophage Infiltration and Polarization in Mice Visible-Light Optical Coherence Tomography Angiography for Monitoring Laser-Induced Choroidal Neovascularization in Mice.Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration Antiangiogenic and Neurogenic Activities of Sleeping Beauty-Mediated PEDF-Transfected RPE Cells In Vitro and In Vivo Angiogenesis and its therapeutic opportunities Risk of choroidal neovascularization among the uveitides.Aflibercept in wet AMD: specific role and optimal use.Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid Inflammatory choroidal neovascular membrane after healed tuberculous choroidal granuloma.Genetic predictors of response to photodynamictherapy.Mechanism of inflammation in age-related macular degeneration Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.SYSTEMIC BETA-BLOCKERS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization.Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation).A case of choroidal neovascular membrane in 6-year-old boy with juvenile idiopathic arthritis.Aflibercept efficacy in refractory choroidal neovascularization.Inhibition of integrin α5β1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model.Theme trends and knowledge structure on choroidal neovascularization: a quantitative and co-word analysis.

P2860

Q26744068-E63CD3BE-AD76-410C-A315-1875E323AE84 Q33930876-09D47BA9-4BAC-4EE1-A943-3CD02192EB5E Q34063100-E006D739-2BF3-46D0-9A40-6FB105DB45A4 Q34678965-FE180383-F9B6-4FC1-87FB-245691FEE28E Q34972337-867F46BF-5819-4D94-9A18-FF8C5D59E657 Q35912788-2C41D474-BC06-459F-895B-907381FE7ED4 Q36060689-679EA223-A2AA-47C9-BC06-404086810CB6 Q36074881-1AA68D61-B789-4952-8A70-A879542E3ED8 Q36088747-D5D42E60-7714-499A-BD98-53AF26EA4F8E Q36369034-3FCE0DA2-073E-4B07-BD38-7A82CF8A7436 Q37101283-2242CF34-179A-461C-A106-811F8813B393 Q37107250-E52BBE63-E439-46A3-A835-992DA8884F9E Q37109788-B781E05E-639B-43BC-B223-A05AABC19BEC Q37250122-3D6B4537-A473-444E-884E-6B033D9D8D61 Q37684354-1B64E83A-1BC4-47B1-9271-8931E409D1EC Q37931236-792AFE8C-2388-4098-A73C-7CFD5C759E11 Q38064846-93D5754A-0C3C-4F37-8888-242B9890724B Q38173896-42DF3834-031F-4D29-99AF-1241E5EBC430 Q38592520-99EF922A-7B13-4B7B-AD46-A32C01F9E2DF Q39550796-A2E8DF0F-5E4E-4DED-A448-A0A0EAF92EDF Q41764457-9D2A0D0F-D05E-4C00-9112-7286D489DDB0 Q41856043-AD6AA94B-6879-4A6A-9A93-334DD79F3143 Q42368348-5B0AE30C-7346-4AA7-873E-D9AC525247D5 Q47116513-FCE6D411-07DE-44F4-BE20-A2711B7D3BC7 Q51744772-CAB844C4-F36B-44DA-B088-D2EFE12B27CD Q52609520-3AFEA020-6B68-47BA-9A16-746E9F74B217

P2860

Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

http://www.wikidata.org/entity/Q37792817

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inflammatory mediators and ang ...... and therapeutic implications.

@en

Inflammatory mediators and ang ...... and therapeutic implications.

@nl

type

label

Inflammatory mediators and ang ...... and therapeutic implications.

@en

Inflammatory mediators and ang ...... and therapeutic implications.

@nl

prefLabel

Inflammatory mediators and ang ...... and therapeutic implications.

@en

Inflammatory mediators and ang ...... and therapeutic implications.

@nl

P1433

Q37792817-1364EA53-78BF-45C6-A19A-B61DFC0C8435

P1476

Q37792817-C9BBCB51-A2A4-4AF2-9FC9-097547456D93

P2093

Q37792817-041A9B48-AF8C-4066-A7F6-FEB62A3BFF19

Q37792817-4BF97F73-AAAF-40AF-9520-438144D02CDB

Q37792817-8EFA86CE-79E7-47A1-9A2B-5567982CBAEB

Q37792817-A2413362-53C7-4EE0-894A-7C72DD4984FB

Q37792817-B7345EE4-0C90-43F9-9A34-D076AE8A0A26

P275

Q37792817-5E67D70E-DD71-4C23-B24F-DECB0DAFEA15

P2860

Q37792817-04829467-9CE2-4A20-9A95-6D00469B89E0

Q37792817-0490BF8C-7B6B-4AAA-8BBE-75BD459CF89B

Q37792817-0969B7AF-7463-4EFA-8896-D66CD9579EF4

Q37792817-0C1BBDC4-5394-4143-BB37-8441FBEDE988

Q37792817-0C931C25-E2A0-4BF3-BA7D-53A333511AB6

Q37792817-0FD0F3C7-1A5D-49BB-9213-AF7CD48F7D58

Q37792817-102F1762-9C01-4540-943D-DD15242AB212

Q37792817-1586731D-82BC-4B70-BEEA-2F4066088637

Q37792817-1A83792C-D50B-4DD6-BF42-93671135A838

Q37792817-1C069EB1-C21E-48CC-94D5-24EF62B0EBB2

P31

Q37792817-080190EA-C5DD-4E5D-AFD2-00E586815B1E

Q37792817-F86D24CE-4639-430D-90BC-54CEA34803BB

P356

Q37792817-4E537E7D-728C-4F1D-ACAC-8525CD2847A0

P478

Q37792817-E48D0734-0D29-487F-B71B-0B2FCB1DA5C1

P50

Q37792817-06266CEC-5793-4D4F-9F92-B9B44EB86039

Q37792817-2EB089E1-500A-462A-8374-E6D4EC07AE08

Q37792817-A2C0F0AF-C851-40CD-AF3E-30CE7F2693A6

P577

Q37792817-5F08BDF6-D58D-4A3A-B416-1477C6DE7D8B

P5875

Q37792817-626BE39B-A771-41CB-A877-7CA36B22C83E

P698

Q37792817-AC6A371F-4211-4866-B39C-E0324846073E

P921

Q37792817-1E56FE67-F1A7-4720-9526-2D16BC7646B9

Q37792817-92307ED3-5985-4C18-AF5B-927A4A861162

Q37792817-BF5F6183-2588-4512-AB99-3A0219C813C9

P932

Q37792817-0DFC8C21-423F-454A-979B-005774AAF62E

P356

P1433

Mediators of Inflammation

P1476

Inflammatory mediators and ang ...... and therapeutic implications.

@en

P2093

Adolfo Sebastiani

http://www.w3.org/2001/XMLSchema#string

Carlo Incorvaia

http://www.w3.org/2001/XMLSchema#string

Claudio Campa

http://www.w3.org/2001/XMLSchema#string

Francesco Parmeggiani

http://www.w3.org/2001/XMLSchema#string

Katia De Nadai

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

CCR3 is a target for age-related macular degeneration diagnosis and therapy

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

Complement factor H polymorphism in age-related macular degeneration

Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes

Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications

P31

scholarly article

P356

10.1155/2010/546826

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P50

Ciro Costagliola

Francesco Semeraro

P577

2010-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46428194

http://www.w3.org/2001/XMLSchema#string

P698

20871825

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

2943126

http://www.w3.org/2001/XMLSchema#string